The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Nice find as per SH3!!
the buying last number of hours ,is it possible some of trades might be US trades ,now that ncyt looks to have caught the attention of Wall street online .
https://www.wallstreet-online.de/nachricht/12939094-novacyt-s-a...
1 day ago · The Novacyt Group is an international diagnostics business generating an increasing portfolio
PROP5 , as seen how difficult to buy at times ,past number of days ,might be when mms filling large orders ,from the trades showing after ,or around end of trading , on Thursday was trying to buy more shares ,and was unable to buy shares until share price had moved up more ,so annoying when unable to buy and watching share price moving upwards with so many shares now looking to be in the hands of people who wanting to hold for a much higher share price ,as share price moves up more ,likely to be more difficult at times to buy ,if mms have a limited number of shares available to them ,
bought some more yesterday , the plan for them is for a 5 year hold ,if share price moves up anywhere near the £21
estimated share price ,thinking a good investment , had missed seeing this estimate until seen a post from routy, had not scrolled down to the bottom
https://walletinvestor.com/lse-stock-forecast/ncyt-stock-prediction#open
I'd say a good solid week!
Alanadale & Wolverine007 , Thanks ,a good day ,so many buys to replace sellers ,also share price moved back up some more again
hope all enjoy a good , safe weekend .
how soon ( not how son )
good volume day ,another day with gradual rise ,and sellers cleared at each level ,and how son the sellers shares have been bought up has shown the demand for shares
DaddyandDylan good post ,your 13,10 post Surely this is the most important sentence in the whole Times article? "Mr Mullis, 57, said that Novacyt faced no constraints in supplying tests to the British government, which has been criticised for shortages".
if this new test, might be the test Government wanting ,or waiting for , can only guess ,
this sentence ,could be so important
And remember it has been mentioned by the company they would find ways other then Rns's to communicate (not verbatim)
That would be fantastic if it were to materialise.
Would also have the added bonus of getting shot of a particular wind up merchant from the AVCT board... for good! :-)
From yesterday’s RNS
“The Company has also developed a plan to expand its Pathflow® brand of products and expects to launch a number of additional tests over the next few months to expand its rapid testing portfolio for infectious diseases.”
Remember GM likes to underplay everything so could see a Covid-19 version in next few weeks - maybe in time for his bonus (October 17th)???
From website:
https://microgenbioproducts.com/pathflow/#1568996087520-8a95c379-6ba4
Microgen pathflow products currently produce results in 15 minutes
Qualitative detection of Influenza A & B from nasopharyngeal, aspirate or throat swab patient samples
* Complete assay, no additional reagents required
* 4 step process with results available after 15 minutes
* Independent flow results for each target antigen
I’d be completely shocked if they aren’t working on a Covid-19 one...
Wouldn’t be at all surprised if they beat AVCT to launch... wouldn’t like to be holding shares over there if that happens.
Would give an instant boost to SP - so much other pieces going on anyway but a nice bonus for sure.